Stay updated on Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe screenshots show minor UI updates to the Study Details page (e.g., formatting and section headings) without changes to the substantive study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check19 days agoChange DetectedAdded a 2025 Nature Medicine publication citation for KEYNOTE-426 (Pembrolizumab plus axitinib vs sunitinib) detailing 5-year survival and biomarker analyses, to the Publications section. Removed the 'Online ahead of print' note for the same article.SummaryDifference0.1%

- Check40 days agoChange DetectedSummary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference2%

- Check48 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0, indicating a new release with presumably added features or fixes.SummaryDifference0.0%

- Check62 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2 (new release). The 'Back to Top' link was removed.SummaryDifference0.1%

- Check69 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.